You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

MINOXIDIL (FOR WOMEN) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Minoxidil (for Women) patents expire, and when can generic versions of Minoxidil (for Women) launch?

Minoxidil (for Women) is a drug marketed by Aurobindo Pharma, P And L, Taro, Apotex Inc, Hikma, L Perrigo Co, and Sight Pharms. and is included in seven NDAs.

The generic ingredient in MINOXIDIL (FOR WOMEN) is minoxidil. There are eight drug master file entries for this compound. One hundred and five suppliers are listed for this compound. Additional details are available on the minoxidil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Minoxidil (for Women)

A generic version of MINOXIDIL (FOR WOMEN) was approved as minoxidil by WATSON LABS on March 3rd, 1987.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MINOXIDIL (FOR WOMEN)?
  • What are the global sales for MINOXIDIL (FOR WOMEN)?
  • What is Average Wholesale Price for MINOXIDIL (FOR WOMEN)?
Summary for MINOXIDIL (FOR WOMEN)
Drug patent expirations by year for MINOXIDIL (FOR WOMEN)
Recent Clinical Trials for MINOXIDIL (FOR WOMEN)

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Industrial Farmacéutica Cantabria, S.A.Phase 1
BioClever 2005 S.L.Phase 3
Industrial Farmacéutica Cantabria, S.A.Phase 3

See all MINOXIDIL (FOR WOMEN) clinical trials

Pharmacology for MINOXIDIL (FOR WOMEN)
Drug ClassArteriolar Vasodilator
Physiological EffectArteriolar Vasodilation

US Patents and Regulatory Information for MINOXIDIL (FOR WOMEN)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma MINOXIDIL (FOR WOMEN) minoxidil AEROSOL, FOAM;TOPICAL 218616-002 Apr 22, 2024 OTC No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Sight Pharms MINOXIDIL (FOR WOMEN) minoxidil SOLUTION;TOPICAL 074743-001 Oct 18, 1996 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Apotex Inc MINOXIDIL (FOR WOMEN) minoxidil SOLUTION;TOPICAL 074924-002 Apr 29, 1998 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
P And L MINOXIDIL (FOR WOMEN) minoxidil AEROSOL, FOAM;TOPICAL 208092-002 Jul 27, 2017 OTC No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Taro MINOXIDIL (FOR WOMEN) minoxidil AEROSOL, FOAM;TOPICAL 209074-002 Apr 22, 2019 OTC No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

MINOXIDIL (FOR WOMEN) Market Analysis and Financial Projection Experimental

Minoxidil for Women: Market Dynamics and Financial Trajectory

Market Overview

The global minoxidil market, particularly for women, is experiencing significant growth driven by increasing demand for effective hair loss treatments. Here are the key dynamics and financial projections for minoxidil in the context of female hair loss.

Global Market Size and Growth

The global minoxidil market is anticipated to grow substantially over the next few years. By 2033, the market size is expected to exceed USD 1.89 billion, growing at a Compound Annual Growth Rate (CAGR) of 4.65% from 2023 to 2033[1].

Regional Market Performance

North America

North America is projected to hold the largest share of the global minoxidil market during the forecast period. The region's robust healthcare infrastructure, heightened awareness of hair-related issues, and lifestyle changes contribute to the high demand for minoxidil products. Increased disposable income also plays a crucial role in driving market growth in this region[1][3].

Europe

Europe is expected to experience the fastest CAGR growth during the forecast period. The market in Europe is influenced by consumer preferences, regulatory frameworks, and economic conditions. Germany, in particular, has shown an uneven but positive trend in demand for minoxidil[1].

Asia-Pacific

The Asia-Pacific region, with its large and growing population, is emerging as a key player in the global minoxidil market. Rapid urbanization and changing lifestyles in countries like China and India are driving the demand for hair care products, including those containing minoxidil[3].

Market Drivers

Several factors are driving the growth of the minoxidil market for women:

Increasing Prevalence of Hair Loss

More than 10% of women experience female pattern hair loss by the age of 50, with this prevalence rising to over 30% by age 70. This increasing prevalence is a significant driver for the demand of minoxidil[2].

Versatility and Effectiveness

Minoxidil is available in various forms, including topical solutions (2% and 5% formulations), foams, and oral tablets. Clinical studies have demonstrated the efficacy of minoxidil in treating female pattern hair loss, with the 5% solution showing the most significant results[2][4].

Consumer Preference and Accessibility

The availability of minoxidil over-the-counter makes it an accessible solution for women seeking to enhance their hair growth. The ease of application and the non-prescription nature of the product further boost its appeal[4].

Clinical Outcomes and Effectiveness

Topical Minoxidil

Topical minoxidil, particularly the 5% solution, has been shown to significantly improve hair density and scalp coverage in women. Studies have demonstrated an average increase of 12.41 hairs per square centimeter compared to placebo recipients[2].

Oral Minoxidil

Oral minoxidil, prescribed off-label, has also shown promising results. A Brazilian study found that patients using oral minoxidil experienced a 12% increase in hair density after 24 weeks, compared to 7.2% in the topical group. Oral minoxidil is favored for its consistent absorption and higher patient compliance[2].

Competitive Analysis

The minoxidil market is competitive, with several key players contributing to its growth. Companies like Hims & Hers Health, Inc. are expanding their product portfolios through collaborations and strategic partnerships. For instance, Hims & Hers announced a collaboration with Walmart to distribute their hair care solutions, including minoxidil products[5].

Growth Factors and Challenges

Growth Factors

  • Increasing research and development activities to expand the use of minoxidil for various hair-related conditions.
  • Growing awareness and demand for hair care products.
  • Robust healthcare infrastructure in key regions.
  • Lifestyle changes and increased disposable income[1][3][5].

Challenges

  • Regulatory frameworks and varying consumer preferences across different regions.
  • Potential side effects and the need for consistent long-term use to maintain results.
  • Economic conditions and cultural attitudes towards personal care in certain regions[3].

Financial Projections

By 2033, the global minoxidil market is expected to reach USD 1.89 billion, growing at a CAGR of 4.65% from 2023 to 2033. Another projection estimates the market to reach USD 1,637.7 million by 2030, growing at a CAGR of 5.2% from 2023 to 2030[1][3].

Analysts’ Views

Analysts highlight the potential for minoxidil beyond its current applications, including its use in treating late alopecia in cancer patients. Such research and development activities are expected to drive market growth further[5].

Key Takeaways

  • The global minoxidil market is growing significantly, driven by increasing demand for hair loss treatments.
  • North America and Europe are key regions driving market growth.
  • Minoxidil is effective in treating female pattern hair loss, with both topical and oral formulations showing promising results.
  • The market is influenced by consumer preferences, regulatory frameworks, and economic conditions.
  • Research and development activities and strategic partnerships are expected to further drive market growth.

FAQs

Q: What is the current market size of the global minoxidil market?

The global minoxidil market was valued at USD 1.2 billion in 2023 and is expected to exceed USD 1.89 billion by 2033[1].

Q: Which region is expected to grow the fastest in the minoxidil market?

Europe is expected to experience the fastest CAGR growth during the forecast period[1].

Q: How effective is minoxidil for women with female pattern hair loss?

Minoxidil has been shown to significantly improve hair density and scalp coverage in women, with the 5% solution being the most effective[2].

Q: What are the different forms of minoxidil available for women?

Minoxidil is available in topical solutions (2% and 5% formulations), foams, and oral tablets[2][4].

Q: What are the potential side effects of using minoxidil?

While minoxidil is generally well-tolerated, potential side effects include itching, redness, and dryness of the scalp. Consistent long-term use is required to maintain results[2][4].

Sources:

  1. Global Minoxidil Market Size, Share, Forecasts To 2033 - Spherical Insights
  2. Minoxidil for Women - Results & Side Effects - Dr. Bonaros
  3. Minoxidil Market Size, Share, Growth and Forecast by 2030 - Meta Stat Insight
  4. Minoxidil: Your Guide To Stimulating Hair Growth - FullyVital
  5. Minoxidil Market Size, Trends and Forecast to 2030 - Coherent Market Insights

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.